Session Information
Date: Thursday, June 8, 2017
Session Title: Dystonia
Session Time: 1:15pm-2:45pm
Location: Exhibit Hall C
Objective: To demonstrate the efficacy and safety of incobotulinumtoxinA and the importance of simultaneous US and EMG guide in targeting single finger muscles in musician’s dystonia
Background: Musician’s dystonia is a task specific movement disorder which presents as loss of voluntary motor control in extensively trained movements. Botulinum toxin (BoNT) injected in dystonic muscles is considered an efficacious treatment (1); US guide has recently been recognize to be useful in the muscle targeting (2).
Methods: musicians affected by upper limb focal dystonia, afferent in the last 3 years to the “Sol Diesis clinic” were clinically analyzed and video recorde by a multispecialist skilled team during musical performance and treated with a EMG-US guided incobotulinumtoxinA injections in the dystonic muscles. Patients were asked to estimate their average playing ability before and after each toxin treatment using a VAS Performance Scale.
Data were statistically analyzed using Student t test.
Results: 15 musicians (mean age 43,9± 14,54; 14 males and 1 female), 10 professional player (3 violin, 4 guitar,1 electric guitar, 1 director, 1 accordion) and 5 professional teachers (4 guitar, 1 flute) were treated. No major side effect were reported (only one case of overshoot weakness after injection); inter-injection intervals were variable; in one case boost injections were performed.
Significant statistically improvement of the VAS Performance Scale after each treatment (22 treatments) was recorded (p< .05) with a mean value of VAS 4.74 ±1.6 pre and 6.63±2.16 post.
10 patients received only one treatment .3 musicians have 3 years follow up with repeated efficacious injections; 8 patients perform regular professional orchestral and soloist activity. Median efficacious dosage on single finger flexors muscle, injected in 12 pts (Flexor digitorum superficialis/profundus) was 11 ± 7.4 U (dilution 100 U in 1 ml). 7 patients associated motor learning techniques with BoNT injections.
Conclusions: IncobotulinumtoxinA can be considered an efficacious treatment in musician’s upper limb dystonia in particular involving finger flexors muscles, also at low dosage, with limited side effects. EMG-US guide is very useful in the diagnostic targeting process and to determine an efficacious dosage.
References: 1) Schuele S et al. Botulinum toxin injections in the treatment of musician’s dystonia.Neurology 2005 .
2) Walter U1, Dressler D Ultrasound-guided botulinum toxin injections in neurology: technique, indications and future perspectives. Expert Rev Neurother. 2014 Aug;14(8):923-36. doi: 10.1586/14737175.2014.936387. Epub 2014 Jul 21.
To cite this abstract in AMA style:
A. Castagna, M. Ramella, G. Giacobbi, P. Cecconi, R. Converti. EMG-US guided incobotulinum toxinA treatment of a cohort of musicians affected by upper limb focal dystonia [abstract]. Mov Disord. 2017; 32 (suppl 2). https://www.mdsabstracts.org/abstract/emg-us-guided-incobotulinum-toxina-treatment-of-a-cohort-of-musicians-affected-by-upper-limb-focal-dystonia/. Accessed November 25, 2024.« Back to 2017 International Congress
MDS Abstracts - https://www.mdsabstracts.org/abstract/emg-us-guided-incobotulinum-toxina-treatment-of-a-cohort-of-musicians-affected-by-upper-limb-focal-dystonia/